ARS Pharmaceuticals Ownership | Who Owns ARS Pharmaceuticals?
ARS Pharmaceuticals Ownership Summary
ARS Pharmaceuticals is owned by 66.02% institutional investors, 23.16% insiders, and 10.83% retail investors. Peregrine capital management is the largest institutional shareholder, holding 0.44% of SPRY shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.05% of its assets in ARS Pharmaceuticals shares.
SPRY Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | ARS Pharmaceuticals | 66.02% | 23.16% | 10.83% |
| Sector | Healthcare Stocks | 88.01% | 8.90% | 3.09% |
| Industry | Biotech Stocks | 109.70% | 8.77% | -18.47% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Peregrine capital management | 423.56K | 0.44% | $4.47M |
| Allspring global investments | 344.17K | 0.35% | $3.63M |
| Rhumbline advisers | 65.16K | 0.07% | $687.46K |
| Wealth enhancement advisory services | 57.62K | 0.06% | $835.55K |
| New york state common retirement fund | 36.34K | 0.04% | $383.00K |
| Legato capital management | 21.46K | 0.02% | $226.41K |
| China universal asset management | 20.61K | 0.02% | $217.40K |
| Tfg advisers | 12.44K | 0.01% | $131.23K |
| Allworth financial lp | 743.00 | 0.00% | $10.07K |
| Avion wealth | 500.00 | 0.00% | $5.00K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Peregrine capital management | 423.56K | 0.13% | $4.47M |
| Tfg advisers | 12.44K | 0.05% | $131.23K |
| Legato capital management | 21.46K | 0.03% | $226.41K |
| China universal asset management | 20.61K | 0.02% | $217.40K |
| Allspring global investments | 344.17K | 0.01% | $3.63M |
| Wealth enhancement advisory services | 57.62K | 0.00% | $835.55K |
| Brown, lisle/cummings | 400.00 | 0.00% | $4.22K |
| Avion wealth | 500.00 | 0.00% | $5.00K |
| Rhumbline advisers | 65.16K | 0.00% | $687.46K |
| New york state common retirement fund | 36.34K | 0.00% | $383.00K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Peregrine capital management | 423.56K | 0.13% | 423.56K |
| Allspring global investments | 344.17K | 0.01% | 165.95K |
| China universal asset management | 20.61K | 0.02% | 1.96K |
| Rhumbline advisers | 65.16K | 0.00% | 1.82K |
| Spire wealth management | 400.00 | 0.00% | 400.00 |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| J.w. cole advisors | - | - | -20.52K |
| New york state common retirement fund | 36.34K | 0.00% | -5.36K |
| Legato capital management | 21.46K | 0.03% | -2.89K |
| Capital performance advisors llp | - | - | -33.00 |
| Gamma investing | 76.00 | 0.00% | -31.00 |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Peregrine capital management | 423.56K | 0.13% | 423.56K | $4.47M |
| Spire wealth management | 400.00 | 0.00% | 400.00 | $4.22K |
| Skopos labs | 47.00 | 0.00% | 47.00 | $496.00 |
Sold Out
| Holder | Change |
|---|---|
| Capital performance advisors llp | -33.00 |
| J.w. cole advisors | -20.52K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 162 | 35.00% | 64,056,669 | 2.41% | 66 | 1.58% | 103 | 51.47% | 26 | 8.33% |
| Jun 30, 2024 | 120 | 1.69% | 62,551,055 | 4.44% | 64 | 1.68% | 68 | 3.03% | 24 | -4.00% |
| Mar 31, 2024 | 118 | 12.38% | 59,892,346 | -8.46% | 62 | 1.35% | 66 | 37.50% | 25 | -16.67% |
| Dec 31, 2023 | 105 | -0.94% | 65,425,953 | -1.66% | 67 | 1.40% | 48 | -20.00% | 30 | 30.43% |
| Sep 30, 2023 | 106 | 7.07% | 66,527,962 | 20.80% | 69 | 2.07% | 60 | -6.25% | 23 | 21.05% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 1.99M | 2.05% | - |
| SPDR® S&P Biotech ETF | 1.53M | 1.57% | -5.66K |
| iShares Russell 2000 ETF | 1.35M | 1.39% | -205.00 |
| Franklin Biotechnology Discv A(acc)USD | 1.23M | 1.26% | - |
| AB Small Cap Growth A | 1.17M | 1.20% | 150.09K |
| MEDICAL BioHealth EUR Acc | 1.12M | 1.15% | 85.00K |
| Fidelity Select Biotechnology | 1.08M | 1.11% | - |
| AB Discovery Growth A | 817.30K | 0.84% | 125.71K |
| Vanguard Institutional Extnd Mkt Idx Tr | 777.20K | 0.80% | -43.01K |
| Franklin Biotechnology Discovery A | 718.99K | 0.74% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jan 06, 2025 | Shawver Laura | - | Sell | $555.07K |
| Dec 17, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sell | $583.52K |
| Dec 17, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sell | $583.58K |
| Dec 17, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | Sell | $583.52K |
| Dec 17, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | Sell | $583.58K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | - | 1 |
| 2024 Q4 | - | 58 |
| 2024 Q3 | - | 51 |
| 2024 Q2 | - | 32 |
| 2024 Q1 | 3 | 44 |
SPRY Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools